Ropacki, M., Gutierrez, S., Domilici, D., Lauterbach, E., Ferrer, M., Liebowitz, M., Donchev, T., Dutina, A., Brenner, R., Kozhuharov, H., Rosenberg, L., Ivkovic, M., Soefje, S., Grant, J., & Faller, D. (2023). Double-blind, randomised placebo-controlled, adaptive phase iib trial with vafidemstat in borderline personality disorder – aggregated baseline characteristics/demographics and safety. Neuroscience Applied, 2, 103854. https://doi.org/10.1016/j.nsa.2023.103854